Analysis: Tibotec drugs zap resistant HIV
"We were able to take the sickest patients -- people with no options and desperately short life expectancy -- and drive their virus levels to undetectable."
- Tony Mills, researcher
Los Angeles, California, USA - Researchers said Thursday that new anti-AIDS drugs can suppress the virus to undetectable levels, even for patients with highly resistant strains of HIV.
In studies that will be published in Saturday's editions of the London-based medical journal 'Lancet,' doctors said that both the experimental non-nucleoside reserve transcriptase etravirine -- TMC125 being developed by Tibotec of Belgium -- and the newly-approved protease inhibitor darunavir -- Prezista, also made by Tibotec -- were efficient in suppressing the virus.